← Open Payments lookup

MICHAEL ALBERT: Open Payments

NPI 1679562094 · RICHLAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$556 in 25 payments from 10 companies in 2025. Trend: 2023 $344 · 2024 $749 · 2025 $556

Food & beverage: $556
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.8$162
Teva Pharmaceuticals USA, Inc.7$141
Neurocrine BioSciences, Inc.2$60
ABBVIE INC.1$44
Lundbeck LLC1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
Bayer Healthcare Pharmaceuticals Inc.1$26
PFIZER INC.1$19
Novo Nordisk Inc1$19
Inari Medical, Inc.1$18

Products named: REXULTI, AUSTEDO XR, INGREZZA, DALVANCE, CAPLYTA, Kerendia, PAXLOVID, Ozempic.

Industry payments across MS — which companies pay providers there.